Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (111-120 of 195) with videos related to

Pageof 20
Sort By:
JAMA Oncology|January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical TrialGabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.
Journal of Psychosocial Oncology|September 12, 2023
Coping strategies and psychosocial resources among women living with metastatic breast cancer: A qualitative studyBlanca S Noriega Esquives, Emily A Walsh, Frank J Penedo, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|October 31, 2007
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerOlga Ivanov, Feng Chen, Elizabeth L Wiley, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Neuro-Oncology Practice|September 27, 2019
Current state of clinical trials in breast cancer brain metastasesJawad Fares, Deepak Kanojia, Alex Cordero, et al.
The New England Journal of Medicine|July 4, 2003
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancerMartin S Tallman, Robert Gray, Nicholas J Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNAQiang Zhang, Zheng Cai, Lorenzo Gerratana, et al.
Journal of the National Cancer Institute|September 14, 2014
Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centersJulian C Schink, Julia R Trosman, Christine B Weldon, et al.
Pageof 20

Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
JAMA Oncology|January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical TrialGabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.
Journal of Psychosocial Oncology|September 12, 2023
Coping strategies and psychosocial resources among women living with metastatic breast cancer: A qualitative studyBlanca S Noriega Esquives, Emily A Walsh, Frank J Penedo, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|October 31, 2007
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerOlga Ivanov, Feng Chen, Elizabeth L Wiley, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Neuro-Oncology Practice|September 27, 2019
Current state of clinical trials in breast cancer brain metastasesJawad Fares, Deepak Kanojia, Alex Cordero, et al.
The New England Journal of Medicine|July 4, 2003
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancerMartin S Tallman, Robert Gray, Nicholas J Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNAQiang Zhang, Zheng Cai, Lorenzo Gerratana, et al.
Journal of the National Cancer Institute|September 14, 2014
Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centersJulian C Schink, Julia R Trosman, Christine B Weldon, et al.
Pageof 20